Combination of Doxorubicin and Berberine Generated Synergistic Anticancer Effect on Breast Cancer Cells Through Down-regulation of Nanog and miRNA-21 Gene Expression
Background: Our purpose was to investigate the effect of berberine (BER) and doxorubicin (DOX) on the expression of stem cell markers Nanog and microRNA- 21 in MCF-7 cells. Methods: The study was an in vitro study employing the human breast cancer cell line MCF-7 that was divided into four group...
Main Authors: | Samia A. Ebeid, Nadia A. Abd El Moneim, Hossam El-Din M. Ghoneim, Sanaa A. El-Benhawy, Samah E. Ismail |
---|---|
Format: | Article |
Language: | English |
Published: |
Shiraz University of Medical Sciences
2020-07-01
|
Series: | Middle East Journal of Cancer |
Subjects: | |
Online Access: | https://mejc.sums.ac.ir/article_46718.html |
Similar Items
-
Berberine Maintains the Neutrophil N1 Phenotype to Reverse Cancer Cell Resistance to Doxorubicin
by: Shuhui Zhang, et al.
Published: (2020-01-01) -
Ratiometric delivery of doxorubicin and berberine by liposome enables superior therapeutic index than DoxilⓇ
by: Ruoshi Zhang, et al.
Published: (2020-05-01) -
Novel functionalized nanoparticles for tumor-targeting co-delivery of doxorubicin and siRNA to enhance cancer therapy
by: Xia Y, et al.
Published: (2017-12-01) -
Effects of berberine on proliferation, cell cycle distribution and apoptosis of human breast cancer T47D and MCF7 cell lines
by: Elmira Barzegar, et al.
Published: (2015-04-01) -
Prognostic significance of NANOG expression in solid tumors: a meta-analysis
by: Zhao LQ, et al.
Published: (2018-09-01)